{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:45:47Z","timestamp":1792802747803,"version":"4.5.0"},"reference-count":248,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.pharmthera.2012.07.010","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T04:25:45Z","timestamp":1343190345000},"page":"106-130","source":"Crossref","is-referenced-by-count":331,"title":["Drug transport by Organic Anion Transporters (OATs)"],"prefix":"10.1016","volume":"136","author":[{"given":"Gerhard","family":"Burckhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.07.010_bb0005","first-page":"369P","article-title":"The interaction between methotrexate and probenecid in man","volume":"63","author":"Aherne","year":"1978","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0010","doi-asserted-by":"crossref","first-page":"31422","DOI":"10.1074\/jbc.M109.024489","article-title":"Interaction of organic cations with organic anion transporters","volume":"284","author":"Ahn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1254\/jphs.93.430","article-title":"Expression of human organic anion transporter in the choroid plexus and their interactions with neurotransmitter metabolites","volume":"93","author":"Aleboyeh","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tox.2008.06.009","article-title":"Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment","volume":"250","author":"Aleksunes","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.105.088583","article-title":"Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules","volume":"315","author":"Anzai","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0030","doi-asserted-by":"crossref","first-page":"45942","DOI":"10.1074\/jbc.M406724200","article-title":"The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus","volume":"279","author":"Anzai","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0026-895X(24)23181-3","article-title":"Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes","volume":"55","author":"Apiwattanakul","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00424-004-1373-3","article-title":"Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells","volume":"450","author":"Asif","year":"2005","journal-title":"Pfl\u00fcgers Arch. - Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.104.001024","article-title":"Xenobiotic and endobiotic transporter mRNA expression in the blood\u2013testis barrier","volume":"33","author":"Augustine","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0167-4889(02)00187-8","article-title":"Role of human organic anion transporter 4 in the transport of ochratoxin A","volume":"1590","author":"Babu","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1254\/jjp.88.69","article-title":"Human organic anion transporters mediate the transport of tetracycline","volume":"88","author":"Babu","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.32.4.424","article-title":"Expression studies and functional characterization of renal human organic anion transporter 1 isoforms","volume":"32","author":"Bahn","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0065","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1074\/jbc.M800737200","article-title":"Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13)","volume":"283","author":"Bahn","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1124\/mol.62.5.1128","article-title":"Interaction of the metal chelator 2,3-dimercapto-1-propane sulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1)","volume":"62","author":"Bahn","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0075","doi-asserted-by":"crossref","first-page":"C1075","DOI":"10.1152\/ajpcell.00619.2004","article-title":"Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites","volume":"289","author":"Bahn","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/bbrc.2000.3230","article-title":"Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene","volume":"275","author":"Bahn","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion transporter 3 (hOAT3) can operate as an exchanger accepting urate as a substrate","volume":"13","author":"Bakhiya","year":"2003","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0090","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1074\/jbc.M808078200","article-title":"Activation of protein kinase C\u03b6 increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport","volume":"284","author":"Barros","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0095","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/00498250600861751","article-title":"Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition","volume":"36","author":"Bleasby","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)","volume":"314","author":"Bleasby","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.105.093070","article-title":"The impact of plasma protein binding on the renal transport of organic anions","volume":"316","author":"Bow","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/geno.1998.5722","article-title":"A novel putative transporter maps top the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse","volume":"56","author":"Brady","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbadis.2006.05.011","article-title":"Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3","volume":"1762","author":"Brandoni","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000069529","article-title":"Compensation increase in organic anion excretion in rats with acute biliary obstruction: role of the renal organic anion transporter 1","volume":"68","author":"Brandoni","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0125","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/hep.21142","article-title":"Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction","volume":"43","author":"Brandoni","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.301.1.145","article-title":"Gender-specific and developmental influences on the expression of rat organic anion transporters","volume":"301","author":"Buist","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/dmd.31.5.559","article-title":"Endocrine regulation of rat organic anion transporters","volume":"31","author":"Buist","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/dmd.32.6.620","article-title":"Rat and mouse differences in gender-predominant expression of organic anion transporter (OAT1-3, SLC22A6-8) mRNA levels","volume":"32","author":"Buist","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0145","doi-asserted-by":"crossref","first-page":"F503","DOI":"10.1152\/ajprenal.00290.2002","article-title":"Transport of cimetidine by flounder and human renal organic anion transporter 1","volume":"284","author":"Burckhardt","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10254-002-0003-8","article-title":"Transport of organic anions across the basolateral membrane of proximal tubule cells","volume":"146","author":"Burckhardt","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0155","series-title":"Drug Transporters","first-page":"29","article-title":"In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy","author":"Burckhardt","year":"2011"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0160","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","article-title":"Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Cha","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0165","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","article-title":"Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta","volume":"275","author":"Cha","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0170","doi-asserted-by":"crossref","first-page":"F247","DOI":"10.1152\/ajprenal.00139.2008","article-title":"Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis","volume":"295","author":"Chen","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0175","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/dmd.111.042036","article-title":"Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs","volume":"40","author":"Cheng","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0180","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00467-005-1863-3","article-title":"Mutational analysis of idiopathic renal hypouricemia","volume":"20","author":"Cheong","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0185","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.106.116517","article-title":"Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein","volume":"321","author":"Chu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/abio.2000.4633","article-title":"Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1","volume":"283","author":"Cihlar","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0195","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0200","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1124\/mol.107.043117","article-title":"Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP","volume":"73","author":"Cropp","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0205","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/AAC.39.6.1247","article-title":"Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients","volume":"39","author":"Cundy","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0210","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1681\/ASN.2006090980","article-title":"Sodium-hydrogen exchanger regulatory factor-1 interacts with mouse urate transporter 1 to regulate renal proximal tubule uric acid transport","volume":"18","author":"Cunningham","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1523-1755.2004.00354.x","article-title":"Characterization of uremic toxin transport by organic anion transporters in the kidney","volume":"65","author":"Deguchi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000110555","article-title":"Elimination of organic anions in response to an early stage of renal ischemia\u2013reperfusion in the rat: role of basolateral plasma transporters and cortical renal blood flow","volume":"81","author":"Di Giusto","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1369\/jhc.2008.951582","article-title":"Oat5 and NaDC1 protein abundance in kidney and urine after renal ischemic reperfusion injury","volume":"57","author":"Di Giusto","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0230","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/ndt\/gfq722","article-title":"URAT1 mutations cause renal hypouricemia type 1 in Iraqui Jews","volume":"26","author":"Dinour","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0235","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jphs.94.297","article-title":"Human organic anion transporter 4 is a renal apical organic anion\/dicarboxylate exchanger in the proximal tubules","volume":"94","author":"Ekaratanawong","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","article-title":"Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human diseases","volume":"9","author":"Enomoto","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate-anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0250","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.301.3.797","article-title":"Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors","volume":"301","author":"Enomoto","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(03)01530-9","article-title":"Interactions of human organic anion as well as cation transporters with indoxyl sulfate","volume":"466","author":"Enomoto","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0260","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0265","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00041552-200309000-00011","article-title":"Novel aspects of renal organic anion transporters","volume":"12","author":"Eraly","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0006-291X(02)02853-X","article-title":"Organic anion and cation transporters occur in pairs of similar and similarly expressed genes","volume":"300","author":"Eraly","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0275","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0006-291X(02)02343-4","article-title":"Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters","volume":"297","author":"Eraly","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0280","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1074\/jbc.M508050200","article-title":"Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knockout mice","volume":"281","author":"Eraly","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0285","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/ajprenal.00272.2005","article-title":"The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics","volume":"290","author":"Erdman","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0290","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi002841o","article-title":"Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3","volume":"40","author":"Feng","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0295","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1021\/bi0200615","article-title":"Role of aromatic transmembrane residues of the organic anion transporter, rOAT3, in substrate recognition","volume":"41","author":"Feng","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/BJ20101904","article-title":"OAT2 catalysis efflux of glutamate and uptake of orotic acid","volume":"436","author":"Fork","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/106002809202600219","article-title":"Methotrexate and non-steroidal antiinflammatory drug interactions","volume":"26","author":"Frenia","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0310","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01213011-200504000-00003","article-title":"Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1)","volume":"15","author":"Fujita","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0315","doi-asserted-by":"crossref","first-page":"44522","DOI":"10.1074\/jbc.M405365200","article-title":"Expression of slc5a8 in kidney and its role in Na+-coupled transport of lactate","volume":"279","author":"Gopal","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0320","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.105.094979","article-title":"Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules","volume":"316","author":"Groves","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0325","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bcp.2004.12.004","article-title":"Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney","volume":"69","author":"Habu","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0330","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0300-9084(02)00022-6","article-title":"Cloning of the pig renal organic anion transporter 1 (pOAT1)","volume":"84","author":"Hagos","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0335","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1681\/ASN.2007010106","article-title":"Torasemide transport by organic anion transporters contributes to hyperuricemia","volume":"18","author":"Hagos","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0340","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.biochi.2005.01.006","article-title":"Functional expression of pig renal organic anion transporter 3 (pOAT3)","volume":"87","author":"Hagos","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0345","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 (hOAT4) operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0350","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/jpet.103.059139","article-title":"Interactions of human organic anion transporters with diuretics","volume":"308","author":"Hasannejad","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0355","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/jpet.102.046847","article-title":"Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat","volume":"305","author":"Hasegawa","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0360","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.300.3.746","article-title":"Functional involvement of rat organic anion transporter 3 (rOAT3; Slc22a8) in the uptake of organic anions","volume":"300","author":"Hasegawa","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0365","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/dmd.32.10.1096","article-title":"Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters","volume":"32","author":"Hashimoto","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00039.2004","article-title":"Molecular physiology of urate transport","volume":"20","author":"Hediger","year":"2005","journal-title":"Physiology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0375","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0380","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0385","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ki.2008.557","article-title":"COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the renal cortex","volume":"75","author":"H\u00f6cherl","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0390","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cpt1977224402","article-title":"Influence of probenecid and spironolacton on furosemide clearance and dynamics in man","volume":"22","author":"Homeida","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0395","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt1977224395","article-title":"Effects of probenecid on furosemide kinetics and natriuresis in man","volume":"22","author":"Honari","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0400","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.ASN.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Hosoyamada","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0405","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.1999.276.1.F122","article-title":"Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney","volume":"276","author":"Hosoyamada","year":"1999","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0410","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-07-4913","article-title":"Interaction of imatinib with human organic ion carriers","volume":"14","author":"Hu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0415","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/toxsci\/63.2.196","article-title":"Assessmant of cisplatin-induced nephrotoxicity by microarray technology","volume":"63","author":"Huang","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","article-title":"Clinical and molecular analysis of patients with renal hypouricemia in Japan \u2014 influence of URAT1 gene on urinary urate excretion","volume":"15","author":"Ichida","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter hOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0430","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/01.ASN.0000135049.20420.E5","article-title":"The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules","volume":"15","author":"Imaoka","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0435","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1124\/dmd.105.006056","article-title":"Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone","volume":"33","author":"Iwanaga","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/jpet.106.112755","article-title":"Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter","volume":"320","author":"Iwanaga","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0445","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ygeno.2007.03.017","article-title":"Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family","volume":"90","author":"Jacobsson","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0450","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3565(24)34949-3","article-title":"The interaction and transport of \u03b2-lactam antibiotics with the cloned rat renal organic anion transporter 1","volume":"290","author":"Jariyawat","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0455","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1523-1755.2002.00464.x","article-title":"Down-regulation of rat organic cation transporter rOCT2 by 5\/6 nephrectomy","volume":"62","author":"Ji","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0460","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1124\/dmd.106.010033","article-title":"Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes","volume":"34","author":"Jigorel","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0465","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0024-3205(01)01296-6","article-title":"Characterization of ochratoxin A transport by human organic anion transporters","volume":"69","author":"Jung","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0470","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0024-3205(02)01500-X","article-title":"Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1","volume":"70","author":"Jung","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0475","doi-asserted-by":"crossref","first-page":"35123","DOI":"10.1074\/jbc.M110.121301","article-title":"Human sodium phosphate transporter 4 (hNPT4\/SLC17A3) as a common renal secretory pathway for drugs and urate","volume":"285","author":"Jutabha","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0480","doi-asserted-by":"crossref","first-page":"23841","DOI":"10.1074\/jbc.M703467200","article-title":"Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members","volume":"282","author":"Kaler","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0485","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbrc.2006.10.136","article-title":"Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions","volume":"351","author":"Kaler","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0490","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/jpet.102.033878","article-title":"Gender difference in the urinary excretion of organic anions in rats","volume":"302","author":"Kato","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0495","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1023\/B:PHAM.0000045244.83999.43","article-title":"Screening of the interaction between xenobiotic transporters and PDZ proteins","volume":"21","author":"Kato","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0500","doi-asserted-by":"crossref","first-page":"F1026","DOI":"10.1152\/ajprenal.00169.2011","article-title":"Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3","volume":"301","author":"Kaufhold","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01381-5","article-title":"Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics","volume":"465","author":"Khamdang","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0510","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":"Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs","volume":"303","author":"Khamdang","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0515","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1254\/jphs.94.197","article-title":"Interaction of human- and rat-organic anion transporters with pravastatin and cimetidine","volume":"94","author":"Khamdang","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0520","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.107.039701","article-title":"Regulation of the tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1\u03b1\/\u03b2 and DNA methylation","volume":"72","author":"Kikuchi","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0525","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.106.025494","article-title":"Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1\u03b1\/\u03b2 and DNA methylation","volume":"70","author":"Kikuchi","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.103.049197","article-title":"Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier","volume":"306","author":"Kikuchi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0535","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfg186","article-title":"Up-regulation of organic anion transporter 1 protein is induced by chronic furosemide or hydrochlorothiazide infusion in rat kidney","volume":"18","author":"Kim","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0540","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2133\/dmpk.20.379","article-title":"Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1","volume":"20","author":"Kimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0545","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2007.09.039","article-title":"Development and characterization of immobilized human organic anion transporter based liquid chromatography stationary phase: hOAT1 and hOAT2","volume":"15","author":"Kimura","year":"2007","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0550","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.301.1.293","article-title":"Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins","volume":"301","author":"Kimura","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0555","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.110.065201","article-title":"The human organic anion transporter genes OAT5 and OAT7 are trans-activated by hepatocyte nuclear factor-1\u03b1 (HNF-1\u03b1)","volume":"78","author":"Klein","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0560","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2005.09.054","article-title":"Mouse organic anion transporter 2 and 3 (mOAT2\/3[Slc22a7\/8]) mediated the renal transport of bumetanide","volume":"524","author":"Kobayashi","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0565","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","article-title":"Transport mechanism and substrate specificity of human organic anion transporter 2 (hOAT2[SLC22A7])","volume":"57","author":"Kobayashi","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0570","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/mol.62.1.7","article-title":"Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice","volume":"62","author":"Kobayashi","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0575","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/dmd.32.5.479","article-title":"Renal transport of organic compounds mediated by mouse organic anion transporter 3 (MOAT3): further substrate specificity of MOAT3","volume":"32","author":"Kobayashi","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0580","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/dmd.104.003301","article-title":"Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver","volume":"33","author":"Kobayashi","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0585","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pfl\u00fcgers Arch. - Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0590","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V134848","article-title":"Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney","volume":"13","author":"Kojima","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0595","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00467-004-1424-1","article-title":"The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia","volume":"19","author":"Komoda","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0600","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1074\/jbc.274.19.13675","article-title":"Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain","volume":"274","author":"Kusuhara","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0605","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1074\/jbc.274.3.1519","article-title":"Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells","volume":"274","author":"Kuze","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0610","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jsbmb.2005.06.028","article-title":"Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter","volume":"97","author":"Kwak","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0615","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.2.4.505","article-title":"Drug\u2013drug interactions involving membrane transporters in the human kidney","volume":"2","author":"Li","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0620","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2133\/dmpk.23.263","article-title":"Effects of angiotensin II receptor blockers on renal handling of uric acid in rats","volume":"23","author":"Li","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0625","doi-asserted-by":"crossref","first-page":"F361","DOI":"10.1152\/ajprenal.00207.2006","article-title":"Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones","volume":"292","author":"Ljubojevic","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0630","doi-asserted-by":"crossref","first-page":"F124","DOI":"10.1152\/ajprenal.00029.2004","article-title":"Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition","volume":"287","author":"Ljubojevic","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0635","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1074\/jbc.272.10.6471","article-title":"Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney","volume":"272","author":"Lopez-Nieto","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0640","doi-asserted-by":"crossref","first-page":"F295","DOI":"10.1152\/ajprenal.1999.276.2.F295","article-title":"Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C","volume":"276","author":"Lu","year":"1999","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0645","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bcp.2006.03.016","article-title":"Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1\u03b1","volume":"72","author":"Maher","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0650","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/187231208783478425","article-title":"Renal and hepatic transporter expression in type 2 diabetic rats","volume":"2","author":"Manautou","year":"2008","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0655","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2010.02.007","article-title":"Therapeutic implications of renal anionic drug transporters","volume":"126","author":"Masereeuw","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0660","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.107.123323","article-title":"Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]","volume":"322","author":"Matsumoto","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0665","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.ki.5002104","article-title":"Downregulation of organic anion transporters in rat kidney under ischemia\/reperfusion-induced acute renal failure","volume":"71","author":"Matsuzaki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0670","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1124\/dmd.107.019828","article-title":"Role of the organic anion transporters in the pharmacokinetics of Zonampanel, and \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, in rats","volume":"36","author":"Minematsu","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0675","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1681\/ASN.2005030306","article-title":"Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins","volume":"16","author":"Miyazaki","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0680","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/pr.55.3.1","article-title":"Impact of drug transporter studies on drug discovery and development","volume":"55","author":"Mizuno","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0685","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1124\/dmd.106.013912","article-title":"Human organic anion transporter 1 (hOAT1\/SLC22A6) and 3 (hOAT3\/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate","volume":"35","author":"Mizuno","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0690","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbrc.2004.08.112","article-title":"Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa","volume":"323","author":"Monte","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0695","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0014-5793(97)01325-2","article-title":"Kidney-specific expression of a novel mouse organic cation transporter-like protein","volume":"417","author":"Mori","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0700","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1471-4159.2004.02552.x","article-title":"Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs","volume":"90","author":"Mori","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0705","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00004647-200304000-00007","article-title":"Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells","volume":"23","author":"Mori","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0710","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0022-3565(24)29490-8","article-title":"Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells","volume":"298","author":"Morita","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0715","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0720","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2004.09.032","article-title":"Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)","volume":"503","author":"Motohashi","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0725","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bjp.0704482","article-title":"Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake","volume":"135","author":"Motojima","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0730","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(24)38862-7","article-title":"Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1","volume":"295","author":"Mulato","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0735","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/mol.61.5.982","article-title":"Expression and functional characterization of rat organic anion transporter 3 (rOAT3) in the choroid plexus","volume":"61","author":"Nagata","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0740","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1046\/j.1523-1755.2000.00005.x","article-title":"Developmental changes in multispecific organic anion transporter 1 expression in rat kidney","volume":"57","author":"Nakajima","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0745","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0750","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0009-9236(03)00060-2","article-title":"Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics","volume":"73","author":"Nishizato","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0755","doi-asserted-by":"crossref","first-page":"F1640","DOI":"10.1152\/ajprenal.00525.2011","article-title":"Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein","volume":"302","author":"Nomura","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0760","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/jpet.103.061812","article-title":"Quantitative evaluation of the drug\u2013drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporter and reduced folate transporter","volume":"309","author":"Nozaki","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0765","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/jpet.107.121491","article-title":"Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices","volume":"322","author":"Nozaki","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0770","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/jpet.106.108233","article-title":"Human organic anion transporter 3 gene is regulated constitutively and inducibly via a cAMP-responsive element","volume":"319","author":"Ogasawara","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0775","doi-asserted-by":"crossref","first-page":"F1819","DOI":"10.1152\/ajprenal.00017.2007","article-title":"Hepatocyte nuclear factor-4\u03b1 regulates the human organic anion transporter 1 gene in the kidney","volume":"292","author":"Ogasawara","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0780","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10038-008-0288-9","article-title":"Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney","volume":"53","author":"Ogasawara","year":"2008","journal-title":"J Hum Genet"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0785","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.103.063370","article-title":"Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood\u2013brain barrier","volume":"309","author":"Ohtsuki","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0790","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.1988.tb03281.x","article-title":"The effect of probenecid on the renal tubular excretion of benzylpenicillin","volume":"25","author":"Overbosch","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0795","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00424-005-1487-2","article-title":"Molecular properties of the SCL13 family of dicarboxylate and sulfate transporters","volume":"451","author":"Pajor","year":"2006","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0800","doi-asserted-by":"crossref","first-page":"38071","DOI":"10.1074\/jbc.M608834200","article-title":"A three-dimensional model of human organic anion transporter 1. Aromatic amino acids required for substrate transport","volume":"281","author":"Perry","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0805","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1124\/mol.104.010223","article-title":"The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4\u03b1 and suppressed by bile acids","volume":"67","author":"Popowski","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0810","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2006030264","article-title":"Human vascular smooth muscle cells express a urate transporter","volume":"17","author":"Price","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0815","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/00498250400015277","article-title":"Renal elimination of a novel and potent \u03b1v\u03b23 integrin antagonist in animals","volume":"34","author":"Prueksaritanont","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0820","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/bbrc.1998.9978","article-title":"Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3)","volume":"255","author":"Race","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0825","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000025863","article-title":"Cloning of a human renal p-aminohippurate transporter, hROAT1","volume":"21","author":"Reid","year":"1998","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0830","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0835","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00424-007-0308-1","article-title":"Gender differences in kidney function","volume":"455","author":"Sabolic","year":"2007","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0840","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.107.128249","article-title":"Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 \u03b1\/\u03b2","volume":"324","author":"Saji","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0845","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/B:PHAM.0000012153.71993.cb","article-title":"Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases","volume":"21","author":"Sakurai","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0850","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11095-007-9401-6","article-title":"Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers","volume":"25","author":"Sato","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0855","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1248\/bpb.33.498","article-title":"Renal secretion of uric acid by organic anion transporter 2 (OAT2\/SLC22A7) in human","volume":"33","author":"Sato","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0860","doi-asserted-by":"crossref","first-page":"F774","DOI":"10.1152\/ajprenal.00326.2003","article-title":"Action of EGF and PGE2 on basolateral organic anion uptake in rabbit proximal renal tubules and hOAT1 expressed in human kidney epithelial cells","volume":"286","author":"Sauvant","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0865","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/01.ASN.0000024437.62046.AF","article-title":"Short-term regulation of basolateral organic anion uptake in proximal tubular OK cells: EGF acts via MAPK, PLA2, and COX1","volume":"13","author":"Sauvant","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0870","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1097\/01.ASN.0000099376.87890.71","article-title":"Short-term regulation of basolateral organic anion uptake in proximal tubular opossum kidney cells: prostaglandin E2 acts via receptor-mediated activation of protein kinase A","volume":"14","author":"Sauvant","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0875","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2005070727","article-title":"Prostaglandin E2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3","volume":"17","author":"Sauvant","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0880","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1124\/jpet.110.168765","article-title":"Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles","volume":"334","author":"Schnabolk","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0885","doi-asserted-by":"crossref","first-page":"F314","DOI":"10.1152\/ajprenal.00497.2005","article-title":"Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20)","volume":"291","author":"Schnabolk","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0890","doi-asserted-by":"crossref","first-page":"F1599","DOI":"10.1152\/ajprenal.00473.2006","article-title":"Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats","volume":"292","author":"Schneider","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0895","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(98)00585-7","article-title":"Identification of multispecific organic anion transporter 2 expressed predominantly in the liver","volume":"429","author":"Sekine","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0900","doi-asserted-by":"crossref","first-page":"18526","DOI":"10.1074\/jbc.272.30.18526","article-title":"Expression cloning and characterization of a novel multispecific organic anion transporter","volume":"272","author":"Sekine","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0905","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1349-7006.2006.00304.x","article-title":"Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats","volume":"97","author":"Shibayama","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0910","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.21596","article-title":"Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate","volume":"45","author":"Shin","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0915","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1146\/annurev.pharmtox.44.101802.121444","article-title":"Evaluation of drug\u2013drug interaction in the hepatobiliary and renal transport of drugs","volume":"45","author":"Shitara","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0920","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1242\/jcs.107.4.1065","article-title":"Molecular cloning and characterization of a novel liver-specific transport protein","volume":"107","author":"Simonson","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0925","doi-asserted-by":"crossref","first-page":"F1021","DOI":"10.1152\/ajprenal.00080.2004","article-title":"Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules","volume":"287","author":"Soodvilai","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0930","doi-asserted-by":"crossref","first-page":"F1057","DOI":"10.1152\/ajprenal.00185.2005","article-title":"Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules","volume":"289","author":"Soodvilai","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0935","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/00498250801927435","article-title":"Physiology, structure, and regulation of the cloned organic anion transporters","volume":"38","author":"Srimaroeng","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0940","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbamem.2005.06.006","article-title":"Structure-activity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolites","volume":"1714","author":"Sugawara","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0945","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/bbrc.2001.4774","article-title":"Isolation of a family of organic anion transporters from human liver and kidney","volume":"283","author":"Sun","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0950","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2004.10.016","article-title":"Organic anion transporter (Slc22a) family members as mediators of toxicity","volume":"204","author":"Sweet","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0955","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.00405.2002","article-title":"Organic anion transporter 3 [Slc22a8] is a dicarboxylate exchanger indirectly coupled to the Na+ gradient","volume":"284","author":"Sweet","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0960","doi-asserted-by":"crossref","first-page":"26934","DOI":"10.1074\/jbc.M203803200","article-title":"Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice","volume":"277","author":"Sweet","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0965","doi-asserted-by":"crossref","first-page":"30088","DOI":"10.1074\/jbc.272.48.30088","article-title":"Expression cloning and characterization of ROAT1","volume":"272","author":"Sweet","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0970","doi-asserted-by":"crossref","first-page":"F972","DOI":"10.1152\/ajprenal.00356.2003","article-title":"Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice","volume":"286","author":"Sykes","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0975","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1124\/jpet.105.094052","article-title":"Is the monkey an appropriate animal model to examine drug\u2013drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists","volume":"316","author":"Tahara","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0980","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.105.088104","article-title":"A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters","volume":"315","author":"Tahara","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0985","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11095-005-2503-0","article-title":"Molecular cloning and functional analysis of OAT1 and OAT3 from Cynomolgus monkey kidney","volume":"22","author":"Tahara","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0990","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(02)02054-X","article-title":"Corrigendum to \u201cInteraction of human organic anion transporters with various cephalosporin antibiotics\u201d","volume":"450","author":"Takeda","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb0995","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01306-7","article-title":"Interaction of human organic anion transporters with various cephalosporin antibiotics","volume":"438","author":"Takeda","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1000","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2003.10.017","article-title":"Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors","volume":"483","author":"Takeda","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1015","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1046\/j.1523-1755.1999.00789.x","article-title":"Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity","volume":"56","author":"Takeda","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1020","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1074\/jbc.M400197200","article-title":"Role of glycosylation in the organic anion transporter OAT1","volume":"279","author":"Tanaka","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1751-7176.2011.00518.x","article-title":"Angiotensin receptor blockers: pharmacology, efficacy, and safety","volume":"13","author":"Taylor","year":"2011","journal-title":"J Clin Hypertens"},{"issue":"8475","key":"10.1016\/j.pharmthera.2012.07.010_bb1030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(86)90786-5","article-title":"Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen","volume":"1","author":"Thyss","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1681\/ASN.V103464","article-title":"Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney","volume":"10","author":"Tojo","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1040","doi-asserted-by":"crossref","first-page":"26391","DOI":"10.1074\/jbc.M111.249292","article-title":"Deletion of multispecific organic anion transporter Oat1\/Slc22a6 protects against mercury-induced kidney injury","volume":"286","author":"Torres","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1045","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1074\/jbc.M708615200","article-title":"Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination","volume":"283","author":"Truong","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000303060","article-title":"Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney","volume":"25","author":"Tsuchida","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1055","doi-asserted-by":"crossref","first-page":"F391","DOI":"10.1152\/ajprenal.00376.2006","article-title":"Cl-dependent up-regulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3","volume":"293","author":"Ueo","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1060","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2005.06.024","article-title":"Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1","volume":"70","author":"Ueo","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1065","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1152\/ajpendo.00257.2002","article-title":"Characterization and identification of steroid sulfate transporters in human placenta","volume":"284","author":"Ugele","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1101\/gr.4356206","article-title":"Functional genomics of membrane transporters in human populations","volume":"16","author":"Urban","year":"2006","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bcp.2007.03.024","article-title":"Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3","volume":"74","author":"Uwai","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(00)00324-1","article-title":"Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1","volume":"398","author":"Uwai","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)38896-2","article-title":"Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1","volume":"295","author":"Uwai","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2133\/dmpk.17.125","article-title":"Rat renal organic anion transporter rOAT1 mediates transport of urinary-excreted cephalosporins, but not of biliary-excreted cefoperazone","volume":"17","author":"Uwai","year":"2002","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2133\/dmpk.19.369","article-title":"Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3","volume":"19","author":"Uwai","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1105","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2008020180","article-title":"Organic anion transporter 3 contributes to the regulation of blood pressure","volume":"19","author":"Vallon","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1110","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1115","doi-asserted-by":"crossref","first-page":"F1332","DOI":"10.1152\/ajprenal.00319.2007","article-title":"Organic anion transporter 3 (Oat3\/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G","volume":"293","author":"Van Wert","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"Van Wert","year":"2010","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.107.042853","article-title":"Organic anion transporter 3 (Oat3\/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin","volume":"74","author":"Van Wert","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11095-007-9407-0","article-title":"Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact on reduced folates","volume":"25","author":"Van Wert","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/rheumatology\/kel205","article-title":"Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout","volume":"46","author":"V\u00e1zquez-Mellado","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1140","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/j.1523-1755.2005.00741.x","article-title":"Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction","volume":"68","author":"Villar","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000166996","article-title":"Time course of organic anion excretion in rats with bilateral ureteral obstruction: role of organic anion transporters (Oat1 and Oat3)","volume":"110","author":"Villar","year":"2008","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1150","first-page":"692","article-title":"Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide","volume":"39","author":"Vree","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1155","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3565(24)39144-X","article-title":"Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs","volume":"294","author":"Wada","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1160","doi-asserted-by":"crossref","first-page":"e35556","DOI":"10.1371\/journal.pone.0035556","article-title":"Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6","volume":"7","author":"Wegner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/jpet.107.125831","article-title":"The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin","volume":"322","author":"Windass","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1170","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/ndt\/gfm219","article-title":"Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of human kidney","volume":"22","author":"Wolff","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1175","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/01.ASN.0000079040.55124.25","article-title":"Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization","volume":"14","author":"Wolff","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1180","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/physrev.00040.2003","article-title":"Molecular and cellular physiology of renal organic cation and anion transport","volume":"84","author":"Wright","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1523-1755.2005.00612.x","article-title":"Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT1 (RST)]","volume":"68","author":"Xu","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1190","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.107.017459","article-title":"Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor","volume":"35","author":"Yamada","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1195","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1211\/jpp.58.11.0011","article-title":"Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4","volume":"58","author":"Yamashita","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000129385","article-title":"Functional and immunochemical characterization of a novel organic anion transporter Oat8 (Slc22a9) in rat renal collecting duct","volume":"21","author":"Yokoyama","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1205","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1152\/ajprenal.00012.2004","article-title":"Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney","volume":"287","author":"Youngblood","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.108.149476","article-title":"Renal organic anion transporter-mediated drug\u2013drug interaction between gemcabene and quinapril","volume":"330","author":"Yuan","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1215","doi-asserted-by":"crossref","first-page":"F999","DOI":"10.1152\/ajprenal.00156.2004","article-title":"Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule","volume":"287","author":"Zhang","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1220","doi-asserted-by":"crossref","first-page":"32570","DOI":"10.1074\/jbc.M800298200","article-title":"Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1225","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1159\/000129073","article-title":"Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia\/reperfusion injury","volume":"28","author":"Zhang","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1230","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/mol.104.007583","article-title":"The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter OAT4","volume":"67","author":"Zhou","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11095-007-9359-4","article-title":"Comparison of the interaction of human organic anion transporter hOAT4 with PDZ proteins between kidney cells and placental cells","volume":"25","author":"Zhou","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.010_bb1240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.taap.2009.06.008","article-title":"Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex","volume":"239","author":"Zlender","year":"2009","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:27:37Z","timestamp":1743834457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":248,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0163725812001593"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.010","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}